2016 Q2 Form 10-Q Financial Statement

#000114420416100132 Filed on May 10, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.940M $3.160M $3.370M
YoY Change 18.07% -6.23% 195.61%
% of Gross Profit
Research & Development $7.519M $8.120M $3.834M
YoY Change 61.08% 111.77% 28.95%
% of Gross Profit
Depreciation & Amortization $18.00K $18.56K $13.90K
YoY Change 12.5% 33.47% 998.26%
% of Gross Profit
Operating Expenses $7.519M $11.28M $3.834M
YoY Change 61.08% 194.18% 28.95%
Operating Profit -$10.45M -$7.203M
YoY Change 46.13% 75.25%
Interest Expense $300.0K $290.0K $60.00K
YoY Change 42.86% 383.33% 50.0%
% of Operating Profit
Other Income/Expense, Net $301.9K $58.27K
YoY Change 42.94% 44.82%
Pretax Income -$10.15M -$10.99M -$7.140M
YoY Change 46.29% 53.92% 75.43%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.15M -$10.99M -$7.145M
YoY Change 46.23% 53.79% 75.56%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$589.1K -$637.8K -$638.6K
COMMON SHARES
Basic Shares Outstanding 17.23M shares 17.23M shares 10.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.50M $58.30M $96.10M
YoY Change -10.18% -39.33% 307.2%
Cash & Equivalents $20.34M $20.40M $96.05M
Short-Term Investments $43.20M $37.90M
Other Short-Term Assets $600.0K $800.0K $283.8K
YoY Change -0.85% 181.85% 9.51%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $64.10M $59.10M $96.34M
YoY Change -10.14% -38.65% 303.16%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $100.0K $173.2K
YoY Change -42.54% -42.28% 1956.36%
Goodwill $12.74M
YoY Change
Intangibles $29.00M
YoY Change
Long-Term Investments $11.40M $23.60M $100.0K
YoY Change -63.92% 23500.0%
Other Assets
YoY Change
Total Long-Term Assets $53.10M $65.40M $41.96M
YoY Change -27.63% 55.85% 497966.26%
TOTAL ASSETS
Total Short-Term Assets $64.10M $59.10M $96.34M
Total Long-Term Assets $53.10M $65.40M $41.96M
Total Assets $117.2M $124.5M $138.3M
YoY Change -19.01% -9.98% 478.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.400M $2.300M $1.300M
YoY Change 84.62% 76.92% -9.42%
Accrued Expenses $2.600M $1.200M $877.5K
YoY Change 177.88% 36.75% 3120.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.000M $3.600M $2.128M
YoY Change 123.22% 69.14% 41.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $11.60M $0.00 $0.00
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.000M $3.600M $2.128M
Total Long-Term Liabilities $11.60M $0.00 $0.00
Total Liabilities $16.60M $15.20M $13.70M
YoY Change 19.94% 10.95% 836.78%
SHAREHOLDERS EQUITY
Retained Earnings -$142.7M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.6M $109.3M $124.6M
YoY Change
Total Liabilities & Shareholders Equity $117.2M $124.5M $138.3M
YoY Change -19.0% -10.01% 478.75%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$10.15M -$10.99M -$7.145M
YoY Change 46.23% 53.79% 75.56%
Depreciation, Depletion And Amortization $18.00K $18.56K $13.90K
YoY Change 12.5% 33.47% 998.26%
Cash From Operating Activities -$6.770M -$9.210M -$3.673M
YoY Change 54.21% 150.72% -29.16%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $2.163K $30.71K
YoY Change -100.0% -92.96% 1086.21%
Acquisitions
YoY Change
Other Investing Activities $6.710M $2.500M
YoY Change -113.76%
Cash From Investing Activities $6.710M $2.500M -$30.71K
YoY Change -113.75% -8240.41% 1086.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 $70.67M
YoY Change -100.0% -100.0% 3908.1%
NET CHANGE
Cash From Operating Activities -6.770M -9.210M -$3.673M
Cash From Investing Activities 6.710M 2.500M -$30.71K
Cash From Financing Activities 0.000 0.000 $70.67M
Net Change In Cash -60.00K -6.710M $66.96M
YoY Change -99.86% -110.02% -2055.38%
FREE CASH FLOW
Cash From Operating Activities -$6.770M -$9.210M -$3.673M
Capital Expenditures $0.00 $2.163K $30.71K
Free Cash Flow -$6.770M -$9.212M -$3.704M
YoY Change 54.92% 148.7% -28.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29091113 USD
CY2016Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
72090 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
66962969 USD
CY2015Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30711 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10916468 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7144953 USD
CY2016Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-201827 USD
CY2015Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2016Q1 us-gaap Depreciation
Depreciation
18558 USD
CY2015Q1 us-gaap Depreciation
Depreciation
13904 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1459855 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9210393 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3673353 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2163 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2497912 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-30711 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
70667033 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6712481 USD
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10451332 USD
CY2015Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3868597 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3231246 shares
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96054082 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
962450 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
283242 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-796010 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
731120 USD
CY2016Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
61394 USD
CY2015Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
158552 USD
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
7951257 USD
CY2015Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
CY2016Q1 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
72090 USD
CY2015Q1 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
0 USD
CY2016Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2015Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
70499993 USD
CY2016Q1 asmb Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
0 USD
CY2015Q1 asmb Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
167040 USD
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1459855 USD
CY2016Q1 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
72090 USD
CY2016Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1459855 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2585780 USD
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1006294 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1628975 USD
CY2016Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
0 USD
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
106777 USD
CY2016Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
236900 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
182752 USD
CY2016Q1 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
0 USD
CY2015Q4 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
120700 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
262956 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
114347 USD
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
ASSEMBLY BIOSCIENCES, INC.
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001426800
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q1 dei Trading Symbol
TradingSymbol
ASMB
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17225662 shares
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17225662 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17225662 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17225662 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17225662 shares
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7121 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16106 USD
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Significant estimates inherent in the preparation of the accompanying financial statements include recoverability and useful lives (indefinite) of intangible assets, assessment of impairment of goodwill, and the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company&#8217;s estimates and could cause actual results to differ from those estimates and assumptions.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 asmb Offering Cost Related To Issuance Of Common Stock
OfferingCostRelatedToIssuanceOfCommonStock
0 USD
CY2015Q1 asmb Offering Cost Related To Issuance Of Common Stock
OfferingCostRelatedToIssuanceOfCommonStock
-60000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
9.42
CY2016Q1 asmb Future Stock Based Compensation Expense Remainder Of Fiscal Year
FutureStockBasedCompensationExpenseRemainderOfFiscalYear
3021844 USD
CY2016Q1 asmb Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
1551027 USD
CY2016Q1 asmb Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
663555 USD
CY2016Q1 asmb Future Stock Based Compensation Expense Year Four
FutureStockBasedCompensationExpenseYearFour
191675 USD
CY2016Q1 asmb Futurestockbasedcompensationexpenseyearfive
Futurestockbasedcompensationexpenseyearfive
2539 USD
CY2016Q1 asmb Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
5430640 USD
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
10130 USD
CY2016Q1 asmb Operating Lease Expiration Month And Year
OperatingLeaseExpirationMonthAndYear
2016-08
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5400000 USD
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y10M24D
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
64770366 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
821585 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
63948781 USD

Files In Submission

Name View Source Status
0001144204-16-100132-index-headers.html Edgar Link pending
0001144204-16-100132-index.html Edgar Link pending
0001144204-16-100132.txt Edgar Link pending
0001144204-16-100132-xbrl.zip Edgar Link pending
asmb-20160331.xml Edgar Link completed
asmb-20160331.xsd Edgar Link pending
asmb-20160331_cal.xml Edgar Link unprocessable
asmb-20160331_def.xml Edgar Link unprocessable
asmb-20160331_lab.xml Edgar Link unprocessable
asmb-20160331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v438463_10q.htm Edgar Link pending
v438463_ex31-1.htm Edgar Link pending
v438463_ex31-2.htm Edgar Link pending
v438463_ex32-1.htm Edgar Link pending
v438463_ex32-2.htm Edgar Link pending